Literature DB >> 17847109

Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients.

A F A Verçosa1, V M B Lorena, C L Carvalho, M F A D Melo, M G A Cavalcanti, E D Silva, A G P Ferreira, V R A Pereira, W V Souza, Y M Gomes.   

Abstract

The wide range of clinical Chagas' disease manifestations, of which heart involvement is the most significant, because of its characteristics, frequency and consequences, and lack of treatment and cure, justify research in this area. Specific immunoglobulin G (IgG) antibody subclasses have been associated with human Chagas' disease. Thus, in this study, the profile of IgG subclasses against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive T. cruzi-specific antigens was correlated with cardiac (CARD, n=33), cardiodigestive (CD, n=7), and indeterminate (IND, n=20) forms of Chagas' disease by indirect enzyme-linked immunosorbent assay (ELISA). IgG subclasses were detected in almost all Chagas patients studied. Nevertheless, only specific IgG2 isotype FRA was found with a significant statistical difference in CARD patients when compared to IND patients. This result suggests the potential use of this isotype for prognostic purposes, for monitoring the progression of chronic Chagas' disease, and for predicting the risk of CARD damage. This is important information, as it could help physicians to evaluate and manage the treatment of their patients. However, a follow-up study is necessary to confirm our result. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17847109      PMCID: PMC6649189          DOI: 10.1002/jcla.20186

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  29 in total

1.  Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test.

Authors:  A A M Gadelha; A F A Verçosa; V M B Lorena; M Nakazawa; A B Carvalho; W V Souza; A G P Ferreira; E D Silva; M A Krieger; S Goldenberg; Y M Gomes
Journal:  Vox Sang       Date:  2003-10       Impact factor: 2.144

2.  Immunization with cytoplasmic repetitive antigen and flagellar repetitive antigen of Trypanosoma cruzi stimulates a cellular immune response in mice.

Authors:  V R A Pereira; V M B Lorena; A P Galvao Da Silva; E M Coutinho; E D Silvas; A G P Ferreira; P Miranda; M A Krieger; S Goldenberg; M B P Soares; R Correa-Oliveira; Y M Gomes
Journal:  Parasitology       Date:  2004-11       Impact factor: 3.234

3.  Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease.

Authors:  M A Krieger; E Almeida; W Oelemann; J J Lafaille; J B Pereira; H Krieger; M R Carvalho; S Goldenberg
Journal:  Am J Trop Med Hyg       Date:  1992-04       Impact factor: 2.345

4.  Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease.

Authors:  F D Cordeiro; O A Martins-Filho; M O Da Costa Rocha; S J Adad; R Corrêa-Oliveira; A J Romanha
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

Review 5.  Immunopathology of Chagas disease.

Authors:  Z A Andrade
Journal:  Mem Inst Oswaldo Cruz       Date:  1999       Impact factor: 2.743

6.  Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.

Authors:  J Morgan; J C Dias; E D Gontijo; L Bahia-Oliveira; R Correa-Oliveira; D G Colley; M R Powell
Journal:  Am J Trop Med Hyg       Date:  1996-10       Impact factor: 2.345

7.  Interaction of human chagasic IgG with human colon muscarinic acetylcholine receptor: molecular and functional evidence.

Authors:  L Sterin-Borda; J C Goin; C R Bilder; G Iantorno; A C Hernando; E Borda
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

8.  Immunodetection of antibodies in sera from symptomatic and asymptomatic Chilean Chagas' disease patients with Trypanosoma cruzi recombinant antigens.

Authors:  M Lorca; A Gonzalez; C Veloso; V Reyes; U Vergara
Journal:  Am J Trop Med Hyg       Date:  1992-01       Impact factor: 2.345

9.  Control of Chagas disease.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2002

10.  Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.

Authors:  A U Krettli; Z Brener
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

View more
  5 in total

1.  Increase in the expression of CD4 + CD25+ lymphocytic T cells in the indeterminate clinical form of human Chagas disease after stimulation with recombinant antigens of Trypanosoma cruzi.

Authors:  Suellen Carvalho de Moura Braz; Adriene Siqueira de Melo; Maria da Glória Aureliano de Melo Cavalcanti; Sílvia Marinho Martins; Wilson de Oliveira; Edimilson Domingos da Silva; Antonio Gomes Pinto Ferreira; Virginia Maria Barros de Lorena; Yara de Miranda Gomes
Journal:  J Clin Immunol       Date:  2014-09-10       Impact factor: 8.317

Review 2.  Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?

Authors:  Elidiana De Bona; Kárita Cláudia Freitas Lidani; Lorena Bavia; Zahra Omidian; Luiza Helena Gremski; Thaisa Lucas Sandri; Iara J de Messias Reason
Journal:  Front Immunol       Date:  2018-08-06       Impact factor: 7.561

3.  Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.

Authors:  Ivonne D Flechas; Adriana Cuellar; Zulma M Cucunubá; Fernando Rosas; Víctor Velasco; Mario Steindel; María del Carmen Thomas; Manuel Carlos López; John Mario González; Concepción Judith Puerta
Journal:  BMC Infect Dis       Date:  2009-11-25       Impact factor: 3.090

4.  IgG Subclass Analysis in Patients with Chagas Disease 4 Years After Benznidazole Treatment.

Authors:  Maurício Llaguno; Marcos Vinícius da Silva; Fernanda Rodrigues Helmo; Lara Rocha Batista; Djalma Alexandre Alves da Silva; Rodrigo Cunha de Sousa; Luiz Antonio Pertili Rodrigues de Resende; Eliane Lages-Silva; Carlo José Freire Oliveira; Juliana Reis Machado; Denise Bertulucci Rocha Rodrigues; Dalmo Correia; Virmondes Rodrigues
Journal:  Acta Parasitol       Date:  2021-06-11       Impact factor: 1.440

5.  Chagas disease-specific antigens: characterization of epitopes in CRA/FRA by synthetic peptide mapping and evaluation by ELISA-peptide assay.

Authors:  Carolina G Bottino; Luciano P Gomes; José B Pereira; José R Coura; David William Provance; Salvatore G De-Simone
Journal:  BMC Infect Dis       Date:  2013-12-03       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.